In vivo evaluation of novel chitosan graft polymeric micelles for delivery of paclitaxel

Drug Delivery

Volumn 18, Issue 3, 2011, Pages 181-189

  Liu, Jia ^a,b   Li, Hongxia ^a,c   Chen, Daquan ^d   Jin, Xiang ^a   Zhao, Xiaoliang ^a   Zhang, Can ^a   Ping, Qineng ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

^c JIANGSU UNIVERSITY   (China)

^d YANTAI UNIVERSITY   (China)

Author keywords

biodistribution; Chitosan graft polymeric micelle; in vivo anti tumor effect; NIR imaging; Paclitaxel; pharmacokinetics

Indexed keywords

CHITOSAN; PACLITAXEL; POLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CANCER SIZE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; KIDNEY; LIVER; LUNG; MICELLE; MOUSE; NEAR INFRARED REFLECTANCE SPECTROSCOPY; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PRIORITY JOURNAL; SPLEEN; TISSUE DISTRIBUTION; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AREA UNDER CURVE; CELL LINE, TUMOR; CHITOSAN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICELLES; PACLITAXEL; POLYMERS; SOLUBILITY; TISSUE DISTRIBUTION;

EID: 79953050650     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2010.520355     Document Type: Article

References (49)

1. Bae, Y., Diezi, T.A., Zhao, A., Kwon, G.S. (2007). Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents. J Contr Rel. 122:324-30. (Pubitemid 47404677)
2. Chen, H., Wang, Y., Xu, J., Ji, J., Zhang, J., Hu, Y., Gu, Y (2008). Non-invasive near infrared fuorescence imaging of CdHgTe quantum dots in mouse model. J Fluoresc 18:801-11.
3. Cho, Y.W., Park, S.A., Han, T.H., Son, D.H., Park, J.S., Oh, SJ., Moon, D.H., Cho, KJ., Ahn, C.H., Byun, Y., Kim, I.S., Kwon, I.C., Kim, S.Y. (2007). In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications. Biomaterials. 28:1236-47. (Pubitemid 44816372)
4. Crosasso, P., Ceruti, M., Brusa, P., Arpicco, S., Dosio, F., Cattel, L. (2000). Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Contr Rel. 63:19-30. (Pubitemid 30046939)
5. Danson, S., Ferry, D., Alakhov, V., Margison, J., Kerr, D., Jowle, D., Brampton, M., Halbert, G., Ranson, M. (2004). Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. Br J Cancer. 90;2085-91. (Pubitemid 38869710)
6. Desai, N., Trieu, V., Yao, Z., Louie, L., Ci, S., Yang, A., Tao, C., De, T., Beals, B., Dykes, D., Noker, P., Yao, R., Labao, E., Hawkins, M., Soon-Shiong, P. (2006). Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res. 12:1317-24. (Pubitemid 43342524)
7. Dhanikula, A.B., Singh, D.R., Panchagnula, R. (2005). In vivo pharmacokinetic and tissue distribution studies in mice of alternative formulations for local and systemic delivery of Paclitaxel: gel, flm, prodrug, liposomes and micelles. Curr Drug Deliv. 2:35-44. (Pubitemid 40590919)
8. Hruby, M., Konak, C., Ulbrich, K. (2005). Polymeric micellar pH-sensitive drug delivery system for doxorubicin. J Contr Rel. 103:137-48. (Pubitemid 40248568)
9. Huh, K.M., Lee, S.C., Cho, Y.W., Lee, J., Jeong, J.H., Park, K. (2005). Hydrotropic polymer micelle system for delivery of paclitaxel. J Contr Rel. 101:59-68. (Pubitemid 39600972)
10. Huh, K.M., Min, H.S., Lee, S.C., Lee, H.J., Kim, S., Park, K. (2008). A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel. J Contr Rel. 126:122-9.
11. Huo, M., Zhang, Y., Zhou, J., Zou, A., Yu, D., Wu, Y., Li, J., Li, H. (2010). Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug. Int J Pharmaceut. 394:162-73.
12. Ibrahim, N.K., Desai, N., Legha, S., Soon-Shiong, P., Teriault, R.L., Rivera, E., Esmaeli, B., Ring, S.E., Bedikian, A., Hortobagyi, G.N., Ellerhorst, J.A. (2002). Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clin Cancer Res. 8:1038-44. (Pubitemid 34517637)
13. Ibrahim, N.K., Samuels, B., Page, R., Doval, D., Patel, K.M., Rao, S.C., Nair, M.K., Bhar, P., Desai, N., Hortobagyi, G.N. (2005). Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer. J Clin Oncol. 23:6019-26.
14. Kim, S.C., Kim, D.W., Shim, Y.H., Bang, J.S., Oh, H.S., Wan Kim, S., Seo, M.H. (2001). In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efcacy. J Contr Rel. 72:191-202. (Pubitemid 32522357)
15. Kwon, G.S. (2003). Polymeric micelles for delivery of poorly water-soluble compounds. Crit Rev Ter Drug Carrier Syst. 20:357-3.
16. Kwon, G.S., Yokoyama, M., Okano, T., Sakurai, Y., Kataoka, K. (1993). Biodistribution of micelle-forming polymer-drug conjugates. Pharm Res. 10:970-4. (Pubitemid 23211417)
17. Lee, A.L., Wang, Y., Cheng, H.Y, Pervaiz, S., Yang, YY (2009). Te co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles. Biomaterials. 30:919-27.
18. Lee, E.S., Gao, Z., Kim, D., Park, K., Kwon, I.C., Bae, YH. (2008). Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specifc TAT exposure and multidrug resistance. J Contr Rel. 129:228-36.
19. Li, H., Liu, J., Ding, S., Zhang, C., Shen, W., You, Q. (2009). Synthesis of novel pH-sensitive chitosan graft copolymers and micellar solubilization of paclitaxel. Int J Biol Macromol. 44:249-56.
20. Liggins, R.T., Burt, H.M. (2004). Paclitaxel-loaded poly(L-lactic acid) microspheres 3: blending low and high molecular weight polymers to control morphology and drug release. Int J Pharm. 282:61-71. (Pubitemid 39178484)
21. Liu, J., Li, H., Jiang, X., Zhang, C., Ping, Q. (2010). Novel pH-sensitive chitosan-derived micelles loaded with paclitaxel. Carbohydr Polym. 82:432-9.
22. Matsumoto, J., Nakada, Y., Sakurai, K., Nakamura, T., Takahashi, Y (1999). Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro. Int J Pharm. 185:93-101. (Pubitemid 29333100)
23. Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y, Shimada, Y., Shirao, K., Okusaka, T., Ueno, H., Ikeda, M., Watanabe, N. (2004). Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer. 91:1775-81. (Pubitemid 39664964)
24. Mizumura, Y., Matsumura, Y., Yokoyama, M., Okano, T., Kawaguchi, T., Moriyasu, F., Kakizoe, T (2002). Incorporation of the anticancer agent KRN5500 into polymeric micelles diminishes the pulmonary toxicity. Jpn J Cancer Res. 93:1237-43. (Pubitemid 36032987)
25. Ooya, T., Lee, J., Park, K. (2003). Efects of ethylene glycol-based graft, star-shaped, and dendritic polymers on solubilization and controlled release of paclitaxel. J Contr Rel. 93:121-7. (Pubitemid 37421354)
26. Qu, G., Yao, Z., Zhang, C., Wu, X., Ping, Q. (2009). PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation. Eur J Pharm Sci. 37:98-105.
27. Rapoport, N. (2007). Physical stimuli-responsive polymeric micelles foranti-cancer drug delivery. Prog Polym Sci. 32:962-90. (Pubitemid 47198285)
28. Rowinsky, E.K., Donehower, R.C. (1993). Te clinical pharmacology of paclitaxel (Taxol). Semin Oncol. 2016-25.
29. Sawant, R.R., Torchilin, V.P. (2009). Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo. Int J Pharm. 374:114-8.
30. Sawant, R.R., Vaze, O., Rockwell, K., Torchilin, V.P. (2010). Palmitoyl ascorbate-modifed liposomes as nanoparticle platform for ascorbate-mediated cytotoxicity and paclitaxel co-delivery. Eur J Pharm Biopharm. 75:321-326
31. Sonnichsen, D.S., Relling, M.V. (1994). Clinical pharmacokinetics of paclitaxel. Clin Pharmacokinet. 27:256-69. (Pubitemid 24315086)
32. Spencer, C.M., Faulds, D. (1994). Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs. 48:794-847. (Pubitemid 24304427)
33. Szebeni, J., Muggia, F.M., Alving, C.R. (1998). Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. J Natl Cancer Inst. 90:300-6. (Pubitemid 28182386)
34. Torchilin, V (2010). Tumor delivery of macromolecular drugs based on the EPR efect. Adv Drug Deliv Rev. (In press).
35. Torchilin, V.P. (2001). Structure and design of polymeric surfactant-based drug delivery systems. J Contr Rel. 73:137-72. (Pubitemid 32544594)
36. Torchilin, V.P. (2007). Micellar nanocarriers: pharmaceutical perspectives. Pharm Res. 24:1-16. (Pubitemid 44902565)
37. van Zuylen, L., Karlsson, M.O., Verweij, J., Brouwer, E., de Bruijn, P., Nooter, K., Stoter, G., Sparreboom, A. (2001). Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles. Cancer Chemother Pharmacol. 47:309-18. (Pubitemid 32640770)
38. Wanjun, T., Cunxin, W., Donghua, C (2005). Kinetic studies on the pyrolysis of chitin and chitosan. Polymer Degr Stab. 87:389-94. (Pubitemid 40146219)
39. Xie, Z., Guan, H., Chen, X., Lu, C., Chen, L., Hu, X., Shi, Q., Jing, X. (2007). A novel polymer-paclitaxel conjugate based on amphiphilic triblock copolymer. J Contr Rel. 117:210-6. (Pubitemid 46161883)
40. Yang, T., Choi, M.K., Cui, F.D., Kim, J.S., Chung, S.J., Shim, C.K., Kim, D.D. (2007). Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. J Contr Rel. 120: 169-77. (Pubitemid 47061489)
41. Yokoyama, M., Miyauchi, M., Yamada, N., Okano, T., Sakurai, Y, Kataoka, K., Inoue, S. (1990). Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res. 50:1693-700. (Pubitemid 20098806)
42. Yokoyama, M., Okano, T., Sakurai, Y., Ekimoto, H., Shibazaki, C., Kataoka, K. (1991). Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res. 51:3229-36.
43. Zhang, C., Ping, Q., Zhang, H., Jian, S. (2003). Preparation of N-alkyl-O-sulfate chitosan derivatives and micellar solubilization of taxol. Carbohydr Polymers. 54:137-44.
44. Zhang, C., Qu, G., Sun, Y., Wu, X., Yao, Z., Guo, Q., Ding, Q., Yuan, S., Shen, Z., Ping, Q., Zhou, H. (2008a). Pharmacokinetics, biodistribution, efcacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Biomaterials. 29:1233-41.
45. Zhang, C., Qu, G., Sun, Y., Yang, T., Yao, Z., Shen, W., Shen, Z., Ding, Q., Zhou, H., Ping, Q. (2008b). Biological evaluation of N-octyl-O-sulfate chitosan as a new nano-carrier of intravenous drugs. Eur J Pharm Sci. 33:415-23.
46. Zhang, J., Chen, H., Xu, L., Gu, Y (2008c). Te targeted behavior of thermally responsive nanohydrogel evaluated by NIR system in mouse model. J Contr Rel. 131:34-40.
47. Zhang, Y., Tang, L., Sun, L., Bao, J., Song, C., Huang, L., Liu, K., Tian, Y, Tian, G., Li, Z., Sun, H., Mei, L. (2010). A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment. Acta Biomater. 6:2045-52.
48. Zhang, Z., Feng, S.S. (2006). Te drug encapsulation efciency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials. 27:4025-33.
49. Zhu, C., Jung, S., Luo, S., Meng, F., Zhu, X., Park, T.G., Zhong, Z. (2010). Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. Biomaterials. 31:2408-16.